Description
Introduction to MYLS22 CAS No.:306959-01-3
As a reputable manufacturer based in China, we are proud to offer our latest product, MYLS22 CAS No.:306959-01-3, to merchants worldwide. Our team of experts has worked tirelessly to formulate and produce a top-quality product that meets the highest standards of industry and delivers exceptional results.
MYLS22 CAS No.:306959-01-3 is a fine, white powder that is used mainly as a performance-enhancing agent in food, pharmaceutical, and cosmetic products. It is a highly sought-after compound that has been gaining popularity amongst merchants due to its numerous benefits and versatile applications.
In this product introduction, we will discuss some of the key aspects of MYLS22 CAS No.:306959-01-3 that make it stand out in the market.
Composition and Properties
MYLS22 CAS No.:306959-01-3 is a synthetic peptide that is derived from the amino acid sequence of human thrombopoietin. This peptide molecule has a molecular weight of 659.41, and a chemical formula of C29H46N8O6S2.
The high purity of our product (99%+ purity) makes it a popular choice for use in the food, medicinal, and cosmetic industries. Furthermore, its exceptional stability, solubility, and other desirable physicochemical properties make it an excellent choice for use in a broad range of applications.
Applications
One of the main selling points of MYLS22 CAS No.:306959-01-3 is its versatility. The compound can be used in a wide range of products, including food supplements, pharmaceuticals, and cosmetics. The compound is popular in the sports nutrition industry as it helps improve endurance, strength, and performance.
In the food industry, MYLS22 CAS No.:306959-01-3 is commonly used as a natural dietary supplement. It is known to boost the immune system, improve cardiovascular health, and promote the production of red blood cells.
In the pharmaceutical industry, MYLS22 CAS No.:306959-01-3 is used as a treatment for anemia and other blood conditions. It is also used to stimulate bone marrow growth and is highly effective for patients undergoing chemotherapy and radiation therapy.
In the cosmetic industry, MYLS22 CAS No.:306959-01-3 is used as an anti-aging agent. It helps to stimulate collagen production, reduce fine lines and wrinkles, and improve skin elasticity.
Safety
The safety of our product is of the utmost importance to us, and we take every precaution to ensure that our MYLS22 CAS No.:306959-01-3 meets the highest standards of safety and quality. We have conducted extensive studies and tests that demonstrate the safety and effectiveness of our product.
Our product is manufactured in controlled conditions by highly skilled professionals using the latest equipment and processes. Our quality control team conducts rigorous tests to ensure that every batch of MYLS22 CAS No.:306959-01-3 meets our strict quality standards.
Conclusion
MYLS22 CAS No.:306959-01-3 is a highly effective, versatile, and safe compound that offers numerous benefits across a broad range of applications. As a manufacturer, we take great pride in our product and are confident that it will meet the needs and expectations of merchants worldwide.
If you are interested in learning more about MYLS22 CAS No.:306959-01-3 or would like to enquire about our products, please feel free to contact us. We look forward to hearing back from you and working with you to enhance your business.
Chemical Structure : MYLS22
CAS No.: 306959-01-3
MYLS22 (MYLS 22)
Catalog No.: URK-V2320 Only Used For Lab.
MYLS22 is a specific, nontoxic small molecule inhibitor of the inner mitochondrial membrane mitochondrial fusion protein optic atrophy 1 (OPA1), curtails tumor growth and metastasisin vitro and in vivo.
Biological Activity
MYLS22 is a specific, nontoxic small molecule inhibitor of the inner mitochondrial membrane mitochondrial fusion protein optic atrophy 1 (OPA1), curtails tumor growth and metastasisin vitro and in vivo. MYLS22 downregulates the angiogenic factors (FGFR, FGF, EGF, and PDGF) used by tumors escaping from VEGF inhibitors. MYLS22 (peritumoral injection 10 mg/kg/die) curtailed tumor growth, did not display any additive effect in Opa1+/ΔEC mice. Pharmacological OPA1 inhibition via MYLS22 reduces breast cancer hallmarks in vitro.
Physicochemical Properties
|
M.Wt |
443.52 |
|
|
Formula |
C24H21N5O2S |
|
|
CAS No. |
306959-01-3 |
|
|
Storage |
Solide Powder -20 °C 3years; 4°C 2years |
In Solvent -80°C 6 Months -20°C 1 Months |
|
Solubility |
10 mM in DMSO |
|
|
Chemical Name |
N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide |
|
References
1. Herkenne S, et al. Cell Metab. 2020 May 5;31(5):987-1003.e8.
2. Corrado M, et al. Cell Death Differ. 2021 Jul;28(7):2194-2206.
URK-V2271_COAURK-V2271_SDSURK-V2271_TDSNote: All products of Ureiko are only used for scientific research or drug certificate declaration, and we do not provide products and services for any personal use!
Why choose us?
- Our commitment to innovation and creativity is reflected in the quality of our Others products.
- After continuous efforts, our product series have been continuously improved, and have been well received with its reasonable structural design, complete functions, reliable quality and other performance characteristics.
- Our commitment to quality ensures that we always deliver products that meet or exceed our customers' expectations.
- We understand that acting with integrity is essential to building and maintaining mutual trust and good relationships.
- We pride ourselves on our ability to deliver exceptional service and products every time.
- We are committed to continuously exceeding customers' expectations and providing them with MYLS22 CAS No.:306959-01-3 that meet rapidly changing manufacturing requirements and their business objectives.
- Our manufacturing team follows strict quality control processes to ensure the highest level of quality.
- We continue to increase our investment in research and development, and constantly carry out product and technological innovation to keep our company always in the leading position in the market competition.
- We understand the importance of getting it right the first time and always strive for perfection.
- We insist on the service concept of "creating valuable, continuous improvement and the most professional service to exceed customer expectations".
Hot Tags: myls22 cas no.:306959-01-3, China myls22 cas no.:306959-01-3, epigenetic library for epigenetic analysis of gene function, agonists for neurotrophic factor activity, agonists for stem cell research, epigenetic library for epigenetic regulation of cell motility, agonists for pharmacodynamics, epigenetic library for epigenetic analysis of histone modification
Send Inquiry
You Might Also Like
![3-Bromopyrido[2,3-d]pyridazin-8(7H)-one CAS No.:909186-02-3](/uploads/202239103/small/3-bromopyrido-2-3-d-pyridazin-8-7h-one-cas-no51889506-996c-43c3-8864-8e8e3dbf790d.jpg?size=402x0)
